Back
Biomarin Pharmaceutical Stock Predictions
Sponsored
BMRN
Sponsored
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager
Sell
33
BMRN
Biomarin Pharmaceutical
Last Price:
71.43
Seasonality Move:
5.7%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.Biomarin Pharmaceutical Stock Forecast
- Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 13.3% based on the past 25 years of stock performance.
- Biomarin Pharmaceutical has risen higher in 15 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Biomarin Pharmaceutical Stock Undervalued?
The current Biomarin Pharmaceutical [BMRN] share price is $71.14. The Score for BMRN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal. - BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Biomarin Pharmaceutical Stock Go Up Next Year?
- Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 13.3% based on the past 25 years of stock performance.
Biomarin Pharmaceutical Stock Rating
Sell
33
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical overpriced?
- Biomarin Pharmaceutical has risen higher in 15 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Biomarin Pharmaceutical Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biomarin.com
52-Week Data
52-Week High:
99.56
52-Week Low:
68.83
Prediction Charts
Market Cap:
13.54B
Price in USD:
71.14
Volume:
2.17M
Beta:
0.88
Technical Analysis
SMA50:
85.93
SMA100:
83.43
SMA200:
87.02
52-Wk Change:
-19.71%
Stock Predictions
-
Is Biomarin Pharmaceutical stock public?
Yes, Biomarin Pharmaceutical is a publicly traded company. -
What is the Biomarin Pharmaceutical stock quote today?
The Biomarin Pharmaceutical stock price is 71.14 USD today. -
How to buy Biomarin Pharmaceutical stock online?
You can buy Biomarin Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Aug-29 | 90.60 | 91.37 | 93.04 | 90.29 |
Aug-30 | 91.46 | 91.17 | 92.35 | 89.95 |
Sep-3 | 91.21 | 91.61 | 92.81 | 90.85 |
Sep-4 | 91.19 | 89.86 | 92.05 | 87.68 |
Sep-5 | 90.01 | 85.13 | 90.01 | 84.89 |
Sep-6 | 85.33 | 84.11 | 86.04 | 83.73 |
Sep-9 | 84.28 | 84.35 | 84.84 | 83.45 |
Sep-10 | 84.48 | 84.85 | 85.64 | 83.69 |
Sep-11 | 84.72 | 84.76 | 84.94 | 83.43 |
Sep-12 | 84.83 | 84.35 | 85.00 | 83.91 |
Sep-13 | 84.43 | 84.90 | 85.00 | 83.95 |
Sep-16 | 77.53 | 69.86 | 78.00 | 69.60 |
Sep-17 | 70.00 | 70.55 | 71.64 | 68.83 |
Sep-18 | 70.87 | 71.14 | 71.58 | 70.11 |
Biomarin Pharmaceutical Earnings
Biomarin Pharmaceutical Earnings Report: Per Share Biomarin Pharmaceutical Earnings Q1 Q2 Q3 and Q4 last year and next year.
Biomarin Pharmaceutical Forecast Revenue Growth
Biomarin Pharmaceutical Stock Analysis: Historical quarterly revenues per share for Biomarin Pharmaceutical and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.